Ionis Pharmaceuticals’ (IONS) “Buy” Rating Reaffirmed at Guggenheim
Ionis Pharmaceuticals (NASDAQ:IONS – Get Free Report)‘s stock had its “buy” rating reaffirmed by equities researchers at ...
Assessing Ionis Pharmaceuticals: Insights From 8 Financial Analysts
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $55.0, with a high ...
Ionis Pharmaceuticals management to meet with Oppenheimer
Meeting to be held in Chicago on April 8 and in San Francisco on April 9 hosted by Oppenheimer. Don't Miss Our End of Quarter Offers: Discover ...
American Association of Individual Investors1d
Which Is a Better Investment, Ionis Pharmaceuticals, Inc. or Moderna, Inc. Stock?
Learn more about whether Ionis Pharmaceuticals, Inc. or Moderna, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
Ionis Pharmaceuticals (NASDAQ:IONS) Coverage Initiated at Redburn Atlantic
Research analysts at Redburn Atlantic began coverage on shares of Ionis Pharmaceuticals (NASDAQ:IONS – Get Free Report) in a ...
Ionis to host expert panel discussion on sHTG
Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) announced today it will host a webinar on Monday, April 14th at 11:00 a.m. ET ...
Fintel on MSN4d
Redburn Atlantic Initiates Coverage of Ionis Pharmaceuticals (IONS) with Neutral Recommendation
Fintel reports that on March 31, 2025, Redburn Atlantic initiated coverage of Ionis Pharmaceuticals (NasdaqGS:IONS) with a ...
TD Cowen Reaffirms Their Buy Rating on Ionis Pharmaceuticals (IONS)
In a report released today, Yaron Werber from TD Cowen maintained a Buy rating on Ionis Pharmaceuticals (IONS – Research Report), with a price ...
Biogen’s tau targeting Alzheimer’s disease therapy gets FDA Fast Track status
Biogen ( NASDAQ: BIIB) said on Wednesday that the U.S. FDA has granted Fast Track designation to BIIB080, its antisense ...